VALPROIC ACID

VALPROIC ACID was reported 31799 times

These side effects are most commonly reported by patients taking VALPROIC ACID:

# Side effect Count
0 DRUG INEFFECTIVE 3836
1 DRUG INTERACTION 3570
2 OFF LABEL USE 2208
3 TOXICITY TO VARIOUS AGENTS 2024
4 SEIZURE 1978
5 COMPLETED SUICIDE 1311
6 SOMNOLENCE 1293
7 DEPRESSION 1230
8 CONDITION AGGRAVATED 1076
9 OVERDOSE 955
10 FOETAL EXPOSURE DURING PREGNANCY 931
11 PYREXIA 886
12 PRODUCT USE IN UNAPPROVED INDICATION 859
13 STATUS EPILEPTICUS 763
14 VOMITING 720
15 FATIGUE 719
16 HYPOTENSION 718
17 PNEUMONIA 690
18 TREMOR 690
19 AGGRESSION 684
20 EPILEPSY 679
21 THROMBOCYTOPENIA 642
22 AGITATION 635
23 HYPERAMMONAEMIA 628
24 DEATH 620
25 NAUSEA 608
26 WEIGHT INCREASED 608
27 CONFUSIONAL STATE 599
28 ANXIETY 587
29 FALL 580
30 INTENTIONAL OVERDOSE 548
31 GAIT DISTURBANCE 546
32 DEPRESSED LEVEL OF CONSCIOUSNESS 543
33 MULTIPLE-DRUG RESISTANCE 543
34 COMA 537
35 DIZZINESS 535
36 NEUROLEPTIC MALIGNANT SYNDROME 520
37 CONVULSION 515
38 DRUG LEVEL INCREASED 504
39 NEUTROPENIA 502
40 DIARRHOEA 492
41 PSYCHOTIC DISORDER 487
42 TREATMENT FAILURE 486
43 INSOMNIA 480
44 DRUG RESISTANCE 478
45 GENERALISED TONIC-CLONIC SEIZURE 477
46 HYPERAMMONAEMIC ENCEPHALOPATHY 473
47 RASH 473
48 ELECTROCARDIOGRAM QT PROLONGED 462
49 SEDATION 445
50 COGNITIVE DISORDER 438
51 HEADACHE 437
52 SUICIDAL IDEATION 431
53 SUICIDE ATTEMPT 430
54 CARDIAC ARREST 425
55 DECREASED APPETITE 413
56 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 413
57 DELIRIUM 395
58 ASTHENIA 394
59 PRODUCT USE ISSUE 391
60 ABNORMAL BEHAVIOUR 380
61 TREATMENT NONCOMPLIANCE 378
62 WEIGHT DECREASED 374
63 ENCEPHALOPATHY 370
64 TACHYCARDIA 366
65 MALAISE 363
66 METABOLIC ACIDOSIS 355
67 DYSARTHRIA 350
68 DYSPNOEA 350
69 IRRITABILITY 348
70 LOSS OF CONSCIOUSNESS 345
71 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 340
72 MATERNAL EXPOSURE DURING PREGNANCY 337
73 CARDIO-RESPIRATORY ARREST 325
74 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 317
75 MENTAL STATUS CHANGES 317
76 ABDOMINAL PAIN 315
77 PAIN 310
78 RHABDOMYOLYSIS 307
79 EXTRAPYRAMIDAL DISORDER 303
80 HYPONATRAEMIA 300
81 PARKINSONISM 300
82 BLOOD CREATINE PHOSPHOKINASE INCREASED 298
83 DRUG ABUSE 298
84 HYPERTENSION 296
85 ACUTE KIDNEY INJURY 295
86 ATAXIA 292
87 SPEECH DISORDER 287
88 EXPOSURE DURING PREGNANCY 286
89 GENERAL PHYSICAL HEALTH DETERIORATION 283
90 LETHARGY 282
91 PNEUMONIA ASPIRATION 282
92 RESPIRATORY FAILURE 282
93 CONSTIPATION 279
94 PETIT MAL EPILEPSY 279
95 DISORIENTATION 278
96 LEUKOPENIA 276
97 DISTURBANCE IN ATTENTION 271
98 MEMORY IMPAIRMENT 262
99 ALANINE AMINOTRANSFERASE INCREASED 261
100 ASPARTATE AMINOTRANSFERASE INCREASED 259
101 SEPSIS 256
102 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 255
103 MYOCLONUS 248
104 STEVENS-JOHNSON SYNDROME 242
105 DYSPHAGIA 236
106 ALTERED STATE OF CONSCIOUSNESS 234
107 SALIVARY HYPERSECRETION 234
108 AMMONIA INCREASED 232
109 DYSKINESIA 231
110 WHITE BLOOD CELL COUNT DECREASED 227
111 PANCYTOPENIA 225
112 SLEEP DISORDER 222
113 ANAEMIA 221
114 MANIA 221
115 FOETAL ANTICONVULSANT SYNDROME 218
116 PSYCHOMOTOR HYPERACTIVITY 217
117 ABORTION SPONTANEOUS 214
118 CATATONIA 211
119 PLATELET COUNT DECREASED 210
120 BALANCE DISORDER 209
121 HEPATIC FAILURE 208
122 BRADYCARDIA 207
123 URINARY TRACT INFECTION 207
124 THERAPY NON-RESPONDER 205
125 RESTLESSNESS 203
126 DRUG INTOLERANCE 202
127 DRUG HYPERSENSITIVITY 201
128 MYOCARDITIS 201
129 PANCREATITIS 201
130 RESPIRATORY ARREST 201
131 UNRESPONSIVE TO STIMULI 198
132 HAEMOGLOBIN DECREASED 197
133 PARANOIA 197
134 DEHYDRATION 196
135 HYPERHIDROSIS 195
136 DEPRESSED MOOD 193
137 PARTIAL SEIZURES 193
138 INTENTIONAL PRODUCT MISUSE 192
139 PANCREATITIS ACUTE 191
140 DYSMORPHISM 190
141 MUSCLE RIGIDITY 188
142 WHITE BLOOD CELL COUNT INCREASED 188
143 HALLUCINATION 186
144 SCHIZOPHRENIA 186
145 SCHIZOAFFECTIVE DISORDER 184
146 SEROTONIN SYNDROME 183
147 TOXIC EPIDERMAL NECROLYSIS 183
148 DISEASE RECURRENCE 182
149 DRUG EXPOSURE DURING PREGNANCY 182
150 BEHAVIOUR DISORDER 180
151 HEPATOTOXICITY 175
152 DRUG-INDUCED LIVER INJURY 174
153 HOSPITALISATION 174
154 PSYCHOMOTOR SKILLS IMPAIRED 172
155 RENAL FAILURE 172
156 HYPOTHERMIA 169
157 INFECTION 169
158 LEUKOCYTOSIS 168
159 PRURITUS 167
160 ALOPECIA 166
161 ABDOMINAL DISTENSION 165
162 COUGH 164
163 HALLUCINATION, AUDITORY 164
164 HEPATIC ENZYME INCREASED 164
165 FEELING ABNORMAL 163
166 POISONING 162
167 PRODUCT DOSE OMISSION ISSUE 161
168 DYSTONIA 158
169 MYOCLONIC EPILEPSY 158
170 MUSCULAR WEAKNESS 155
171 DISEASE PROGRESSION 154
172 DRUG TOXICITY 151
173 OXYGEN SATURATION DECREASED 151
174 PLEURAL EFFUSION 151
175 HYPERNATRAEMIA 150
176 MENTAL IMPAIRMENT 150
177 DRUG LEVEL DECREASED 149
178 MIGRAINE 149
179 MUSCULOSKELETAL STIFFNESS 148
180 RESPIRATORY DEPRESSION 148
181 ACUTE HEPATIC FAILURE 147
182 BRAIN OEDEMA 147
183 PRESCRIBED OVERDOSE 146
184 TOXIC ENCEPHALOPATHY 146
185 C-REACTIVE PROTEIN INCREASED 145
186 HYPOGLYCAEMIA 145
187 SHOCK 144
188 SYNCOPE 144
189 ARRHYTHMIA 143
190 PSYCHIATRIC DECOMPENSATION 142
191 HYPOTONIA 139
192 HYPOXIA 139
193 MULTIPLE ORGAN DYSFUNCTION SYNDROME 139
194 DELUSION 138
195 VISION BLURRED 138
196 DEVELOPMENTAL DELAY 136
197 EOSINOPHILIA 135
198 INTENTIONAL PRODUCT USE ISSUE 135
199 RASH MACULO-PAPULAR 134
200 URINARY INCONTINENCE 134
201 GRAND MAL CONVULSION 133
202 AKATHISIA 132
203 DRUG LEVEL BELOW THERAPEUTIC 132
204 COORDINATION ABNORMAL 130
205 ADVERSE DRUG REACTION 129
206 DEPRESSIVE SYMPTOM 129
207 OEDEMA PERIPHERAL 129
208 TRANSAMINASES INCREASED 129
209 HYPOKALAEMIA 128
210 PAIN IN EXTREMITY 128
211 APHASIA 127
212 INTENTIONAL SELF-INJURY 126
213 NYSTAGMUS 126
214 MENTAL DISORDER 125
215 DIABETES MELLITUS 123
216 HYPERSENSITIVITY 123
217 BLOOD CREATININE INCREASED 122
218 COAGULOPATHY 122
219 BACK PAIN 121
220 DRUG WITHDRAWAL SYNDROME 121
221 DIPLOPIA 120
222 INCORRECT DOSE ADMINISTERED 120
223 THERAPEUTIC RESPONSE DECREASED 120
224 ERYTHEMA 119
225 THERAPY PARTIAL RESPONDER 119
226 WITHDRAWAL SYNDROME 119
227 HYPOTHYROIDISM 118
228 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 118
229 ABDOMINAL PAIN UPPER 117
230 ARTHRALGIA 116
231 HEPATIC FUNCTION ABNORMAL 116
232 SEPTIC SHOCK 114
233 TEARFULNESS 114
234 ANTICONVULSANT DRUG LEVEL INCREASED 113
235 CHEST PAIN 113
236 DRUG DEPENDENCE 113
237 PSYCHOMOTOR RETARDATION 113
238 HALLUCINATION, VISUAL 112
239 MUSCLE SPASMS 112
240 DEPRESSION SUICIDAL 111
241 HEART RATE INCREASED 111
242 MEDICATION ERROR 111
243 MYALGIA 111
244 NEUTROPHIL COUNT DECREASED 111
245 CEREBRAL ATROPHY 110
246 CEREBROVASCULAR ACCIDENT 110
247 GAMMA-GLUTAMYLTRANSFERASE INCREASED 110
248 PARADOXICAL DRUG REACTION 110
249 RESPIRATORY DISTRESS 110
250 ATRIAL SEPTAL DEFECT 109
251 INTESTINAL ISCHAEMIA 109
252 BLOOD GLUCOSE INCREASED 108
253 RENAL IMPAIRMENT 108
254 SOPOR 108
255 HYPOCALCAEMIA 106
256 HYPOSPADIAS 105
257 ELECTROENCEPHALOGRAM ABNORMAL 104
258 COVID-19 103
259 SINUS TACHYCARDIA 103
260 SPEECH DISORDER DEVELOPMENTAL 101
261 VENTRICULAR SEPTAL DEFECT 101
262 HYPERGLYCAEMIA 100
263 LACTIC ACIDOSIS 100
264 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 99
265 PREMATURE BABY 99
266 ATRIAL FIBRILLATION 97
267 MATERNAL DRUGS AFFECTING FOETUS 97
268 MOTOR DYSFUNCTION 97
269 ANTIPSYCHOTIC DRUG LEVEL INCREASED 96
270 BLOOD PRESSURE DECREASED 96
271 CHILLS 95
272 AGRANULOCYTOSIS 94
273 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 94
274 ABDOMINAL DISCOMFORT 93
275 TYPE 2 DIABETES MELLITUS 93
276 VISUAL IMPAIRMENT 93
277 MOOD ALTERED 92
278 TARDIVE DYSKINESIA 92
279 APATHY 91
280 BLOOD ALKALINE PHOSPHATASE INCREASED 91
281 HYPERSOMNIA 91
282 PULMONARY EMBOLISM 91
283 LIVER INJURY 90
284 URINARY RETENTION 90
285 BIPOLAR DISORDER 89
286 CARDIAC FAILURE 89
287 DEEP VEIN THROMBOSIS 89
288 VERTIGO 89
289 ACCIDENTAL OVERDOSE 88
290 AFFECT LABILITY 88
291 AMNESIA 88
292 BLOOD PRESSURE INCREASED 88
293 CRYING 88
294 TONIC CONVULSION 88
295 FANCONI SYNDROME 87
296 HAEMORRHAGE 87
297 OEDEMA 87
298 MULTIPLE DRUG OVERDOSE 86
299 PARAESTHESIA 86
300 DEMENTIA 85
301 PERICARDIAL EFFUSION 85
302 RENAL FAILURE ACUTE 85
303 SPINA BIFIDA 85
304 ANGER 84
305 AUTISM SPECTRUM DISORDER 84
306 INTERNATIONAL NORMALISED RATIO INCREASED 84
307 NEUTROPHIL COUNT INCREASED 84
308 RED BLOOD CELL COUNT DECREASED 84
309 INFLUENZA 83
310 OCULOGYRIC CRISIS 83
311 PULMONARY OEDEMA 83
312 DYSPEPSIA 82
313 NERVOUSNESS 82
314 NEUROTOXICITY 82
315 TALIPES 82
316 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 82
317 ANTICONVULSANT DRUG LEVEL DECREASED 81
318 HEPATITIS 81
319 NASOPHARYNGITIS 81
320 OBESITY 81
321 TACHYPNOEA 81
322 UNDERDOSE 81
323 GASTROINTESTINAL DISORDER 80
324 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 80
325 NERVOUS SYSTEM DISORDER 80
326 NO ADVERSE EVENT 80
327 STUPOR 80
328 BLISTER 79
329 MYDRIASIS 79
330 PRODUCT SUBSTITUTION ISSUE 79
331 HYPERTHERMIA 78
332 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 78
333 CIRCULATORY COLLAPSE 77
334 CONGENITAL NOSE MALFORMATION 77
335 HYPERKALAEMIA 77
336 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 77
337 BLOOD LACTIC ACID INCREASED 76
338 PALPITATIONS 76
339 HAEMODYNAMIC INSTABILITY 75
340 HYPOKINESIA 75
341 HEPATIC STEATOSIS 74
342 INFLUENZA LIKE ILLNESS 74
343 INTELLECTUAL DISABILITY 74
344 MULTI-ORGAN FAILURE 74
345 LYMPHADENOPATHY 73
346 PERSECUTORY DELUSION 73
347 HYPOMANIA 72
348 LIVER FUNCTION TEST ABNORMAL 72
349 PALLOR 72
350 DIABETIC KETOACIDOSIS 71
351 DRY MOUTH 71
352 HYPERTONIA 71
353 ILEUS PARALYTIC 71
354 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 71
355 MOOD SWINGS 71
356 MOVEMENT DISORDER 71
357 REBOUND EFFECT 71
358 CARDIOMEGALY 70
359 HYPOAESTHESIA 70
360 ILEUS 70
361 MOBILITY DECREASED 70
362 MUSCLE TWITCHING 70
363 POISONING DELIBERATE 70
364 TUBULOINTERSTITIAL NEPHRITIS 70
365 UPPER RESPIRATORY TRACT INFECTION 70
366 AFFECTIVE DISORDER 69
367 ILLNESS 69
368 LIVER DISORDER 69
369 ORTHOSTATIC HYPOTENSION 69
370 THINKING ABNORMAL 69
371 BLOOD LACTATE DEHYDROGENASE INCREASED 68
372 RASH ERYTHEMATOUS 68
373 ADVERSE EVENT 67
374 DRUG WITHDRAWAL CONVULSIONS 67
375 FOOT DEFORMITY 67
376 BRADYKINESIA 66
377 HEAD INJURY 66
378 SUSPECTED SUICIDE 66
379 HAEMATOCRIT DECREASED 65
380 PROPOFOL INFUSION SYNDROME 65
381 SUDDEN DEATH 65
382 ASPIRATION 63
383 MALIGNANT NEOPLASM PROGRESSION 63
384 METABOLIC ENCEPHALOPATHY 63
385 ACIDOSIS 62
386 NECK PAIN 62
387 PSYCHOGENIC SEIZURE 62
388 CONTUSION 61
389 ATONIC SEIZURES 60
390 EUPHORIC MOOD 60
391 FEAR 60
392 OSTEOPENIA 59
393 CONTRAINDICATED PRODUCT ADMINISTERED 58
394 CYANOSIS 58
395 ERECTILE DYSFUNCTION 58
396 INJURY 58
397 ACUTE RESPIRATORY DISTRESS SYNDROME 57
398 ACUTE RESPIRATORY FAILURE 57
399 APNOEA 57
400 DROOLING 57
401 MIOSIS 57
402 PATENT DUCTUS ARTERIOSUS 57
403 SEIZURE CLUSTER 57
404 STILLBIRTH 57
405 URTICARIA 57
406 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 56
407 BLOOD BILIRUBIN INCREASED 56
408 FEBRILE NEUTROPENIA 56
409 FOCAL DYSCOGNITIVE SEIZURES 56
410 LIP DISORDER 56
411 MYOCARDIAL INFARCTION 56
412 PSYCHIATRIC SYMPTOM 56
413 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 55
414 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 55
415 EPISTAXIS 55
416 HYPERPROLACTINAEMIA 55
417 RESPIRATORY ACIDOSIS 55
418 RESPIRATORY DISORDER 55
419 BODY TEMPERATURE INCREASED 54
420 HEPATOMEGALY 54
421 HYPOPHAGIA 54
422 INTENTIONAL DRUG MISUSE 54
423 LYMPHOCYTE COUNT DECREASED 54
424 NECROSIS ISCHAEMIC 54
425 POOR QUALITY SLEEP 54
426 SKULL MALFORMATION 54
427 VENTRICULAR FIBRILLATION 54
428 ASTHMA 53
429 BLOOD CHOLESTEROL INCREASED 53
430 EMOTIONAL DISORDER 53
431 GASTROOESOPHAGEAL REFLUX DISEASE 53
432 GAZE PALSY 53
433 HOMICIDAL IDEATION 53
434 HYPERKINESIA 53
435 IMPULSIVE BEHAVIOUR 53
436 INCREASED APPETITE 53
437 PERIPHERAL SWELLING 53
438 DRUG ERUPTION 52
439 CEREBELLAR ATROPHY 51
440 ANGIOEDEMA 50
441 CEREBRAL HAEMORRHAGE 50
442 CHRONIC KIDNEY DISEASE 50
443 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 50
444 HEMIPARESIS 50
445 OROPHARYNGEAL PAIN 50
446 POSTURE ABNORMAL 50
447 PROTEINURIA 50
448 SLEEP APNOEA SYNDROME 50
449 SUBILEUS 50
450 THERAPEUTIC RESPONSE UNEXPECTED 50
451 UNEVALUABLE EVENT 50
452 VENTRICULAR TACHYCARDIA 50
453 WRONG PATIENT RECEIVED PRODUCT 50
454 BRAIN INJURY 49
455 DRUG DOSE OMISSION 49
456 ELECTROLYTE IMBALANCE 49
457 EOSINOPHIL COUNT DECREASED 49
458 HAEMATOMA 49
459 HYPERTRANSAMINASAEMIA 49
460 SKIN LESION 49
461 STOMATITIS 49
462 BRADYPHRENIA 48
463 CAESAREAN SECTION 48
464 CELLULITIS 48
465 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48
466 CRYPTORCHISM 48
467 DISCOMFORT 48
468 ENCEPHALITIS 48
469 FAECALOMA 48
470 STAPHYLOCOCCAL INFECTION 48
471 TROPONIN INCREASED 48
472 ACIDOSIS HYPERCHLORAEMIC 47
473 FEEDING DISORDER 47
474 HEPATIC ENCEPHALOPATHY 47
475 LOWER RESPIRATORY TRACT INFECTION 47
476 NEPHROLITHIASIS 47
477 NO THERAPEUTIC RESPONSE 47
478 PRESCRIBED UNDERDOSE 47
479 PRODUCT PRESCRIBING ERROR 47
480 ATELECTASIS 46
481 DRUG LEVEL ABOVE THERAPEUTIC 46
482 FACE OEDEMA 46
483 JAUNDICE 46
484 PSYCHOTIC SYMPTOM 46
485 BLOOD UREA INCREASED 45
486 BONE MARROW FAILURE 45
487 BRUXISM 45
488 CHOKING 45
489 DRUG EFFECT INCOMPLETE 45
490 GASTROINTESTINAL HAEMORRHAGE 45
491 GENE MUTATION 45
492 HYPOALBUMINAEMIA 45
493 LEARNING DISORDER 45
494 RASH GENERALISED 45
495 SWELLING 45
496 SYNDACTYLY 45
497 TORSADE DE POINTES 45
498 BLOOD SODIUM DECREASED 44
499 DEAFNESS 44
500 EYE DISORDER 44
501 FEMUR FRACTURE 44
502 LUNG DISORDER 44
503 SINUS BRADYCARDIA 44
504 STRESS 44
505 SWELLING FACE 44
506 ABDOMINAL TENDERNESS 43
507 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 43
508 BLOOD ALBUMIN DECREASED 43
509 CARDIAC DISORDER 43
510 CLEFT PALATE 43
511 EATING DISORDER 43
512 EOSINOPHILIC PLEURAL EFFUSION 43
513 INTESTINAL OBSTRUCTION 43
514 LIMB MALFORMATION 43
515 THROMBOTIC MICROANGIOPATHY 43
516 CHOLESTASIS 42
517 DYSGRAPHIA 42
518 EMOTIONAL DISTRESS 42
519 EXCESSIVE EYE BLINKING 42
520 HAEMATURIA 42
521 HYPERLACTACIDAEMIA 42
522 MULTIPLE SCLEROSIS 42
523 PERICARDITIS 42
524 RESTING TREMOR 42
525 CARDIOGENIC SHOCK 41
526 DERMATITIS ALLERGIC 41
527 DYSPHONIA 41
528 FLUSHING 41
529 MAJOR DEPRESSION 41
530 MICROCEPHALY 41
531 PREGNANCY 41
532 PREMATURE DELIVERY 41
533 PRODUCT ADMINISTRATION ERROR 41
534 RESPIRATORY TRACT INFECTION 41
535 THERAPEUTIC PRODUCT EFFECT DECREASED 41
536 CHOREOATHETOSIS 40
537 DEVELOPMENTAL HIP DYSPLASIA 40
538 DYSURIA 40
539 GRANULOCYTOPENIA 40
540 HYPERREFLEXIA 40
541 INFANTILE SPASMS 40
542 METABOLIC DISORDER 40
543 MITOCHONDRIAL DNA MUTATION 40
544 PRODUCT QUALITY ISSUE 40
545 SEDATION COMPLICATION 40
546 VIRAL INFECTION 40
547 ACCIDENTAL DEATH 39
548 BRONCHITIS 39
549 CHANGE IN SEIZURE PRESENTATION 39
550 CONGENITAL ANOMALY 39
551 CRANIOSYNOSTOSIS 39
552 DECREASED EYE CONTACT 39
553 ENURESIS 39
554 HAEMATEMESIS 39
555 HAEMODIALYSIS 39
556 HYPERLIPIDAEMIA 39
557 INFLAMMATION 39
558 LIVER FUNCTION TEST INCREASED 39
559 MENINGOMYELOCELE 39
560 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 39
561 PSORIASIS 39
562 TRISMUS 39
563 CARNITINE DEFICIENCY 38
564 GAIT INABILITY 38
565 HYPOMAGNESAEMIA 38
566 HYPOPHOSPHATAEMIA 38
567 INCONTINENCE 38
568 JOINT INJURY 38
569 NEUROPATHY PERIPHERAL 38
570 PANIC ATTACK 38
571 PRIAPISM 38
572 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 38
573 ROAD TRAFFIC ACCIDENT 38
574 SINUS RHYTHM 38
575 TOXIC SKIN ERUPTION 38
576 ABORTION INDUCED 37
577 BLOOD GLUCOSE DECREASED 37
578 COLITIS 37
579 COMMUNICATION DISORDER 37
580 ILL-DEFINED DISORDER 37
581 LEARNING DISABILITY 37
582 LOGORRHOEA 37
583 MOUTH ULCERATION 37
584 THERAPY INTERRUPTED 37
585 BIPOLAR I DISORDER 36
586 BLOOD POTASSIUM INCREASED 36
587 BLOOD TRIGLYCERIDES INCREASED 36
588 BRADYPNOEA 36
589 CARDIAC MURMUR 36
590 DECREASED ACTIVITY 36
591 DRUG EFFECT DECREASED 36
592 EYE MOVEMENT DISORDER 36
593 HYPOVENTILATION 36
594 LOW BIRTH WEIGHT BABY 36
595 MULTIPLE DRUG OVERDOSE INTENTIONAL 36
596 OSTEOPOROSIS 36
597 PETECHIAE 36
598 PURPURA 36
599 RASH MACULAR 36
600 REFUSAL OF TREATMENT BY PATIENT 36
601 SOCIAL AVOIDANT BEHAVIOUR 36
602 WRONG PRODUCT ADMINISTERED 36
603 ANURIA 35
604 ASTERIXIS 35
605 BRAIN DEATH 35
606 CEREBRAL INFARCTION 35
607 CHEST DISCOMFORT 35
608 DIABETES INSIPIDUS 35
609 HEPATOCELLULAR INJURY 35
610 HYPERVENTILATION 35
611 INCOHERENT 35
612 INTRA-ABDOMINAL PRESSURE INCREASED 35
613 MUSCULOSKELETAL PAIN 35
614 POLYDACTYLY 35
615 POLYDIPSIA 35
616 POLYNEUROPATHY 35
617 SKIN DISCOLOURATION 35
618 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 35
619 SUICIDAL BEHAVIOUR 35
620 SUPRAVENTRICULAR TACHYCARDIA 35
621 VISUAL ACUITY REDUCED 35
622 BURNING SENSATION 34
623 CLONUS 34
624 CONJUNCTIVITIS 34
625 GASTROINTESTINAL SOUNDS ABNORMAL 34
626 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 34
627 HEPATITIS CHOLESTATIC 34
628 HYPERACUSIS 34
629 HYPERTRIGLYCERIDAEMIA 34
630 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 34
631 JOINT SWELLING 34
632 OPPOSITIONAL DEFIANT DISORDER 34
633 PLEUROTHOTONUS 34
634 PRODUCT PREPARATION ISSUE 34
635 RENAL TUBULAR ACIDOSIS 34
636 SCREAMING 34
637 ABSCESS 33
638 ATTENTION DEFICIT HYPERACTIVITY DISORDER 33
639 COMPLEX PARTIAL SEIZURES 33
640 DISINHIBITION 33
641 EAR INFECTION 33
642 HEAD DISCOMFORT 33
643 HEART DISEASE CONGENITAL 33
644 INTESTINAL PERFORATION 33
645 LANGUAGE DISORDER 33
646 NEUROLOGICAL SYMPTOM 33
647 PRODUCTIVE COUGH 33
648 QUADRIPARESIS 33
649 RASH PRURITIC 33
650 RESTLESS LEGS SYNDROME 33
651 SCOLIOSIS 33
652 STREPTOCOCCAL INFECTION 33
653 AMENORRHOEA 32
654 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 32
655 ANTIPSYCHOTIC DRUG LEVEL DECREASED 32
656 CHOLELITHIASIS 32
657 DISSEMINATED INTRAVASCULAR COAGULATION 32
658 DYSPHORIA 32
659 ERYTHEMA MULTIFORME 32
660 HEPATIC CYTOLYSIS 32
661 HYPERBILIRUBINAEMIA 32
662 RED CELL DISTRIBUTION WIDTH INCREASED 32
663 SKIN EXFOLIATION 32
664 TRICUSPID VALVE INCOMPETENCE 32
665 TYPE 1 DIABETES MELLITUS 32
666 ANHEDONIA 31
667 ARNOLD-CHIARI MALFORMATION 31
668 ASTIGMATISM 31
669 AUTONOMIC NERVOUS SYSTEM IMBALANCE 31
670 BLOOD PRESSURE SYSTOLIC INCREASED 31
671 BLOOD PROLACTIN INCREASED 31
672 CEREBRAL DISORDER 31
673 COMA SCALE ABNORMAL 31
674 ELECTROCARDIOGRAM ABNORMAL 31
675 EOSINOPHIL COUNT INCREASED 31
676 GINGIVAL HYPERTROPHY 31
677 HAEMANGIOMA 31
678 HAEMATOCHEZIA 31
679 HYDROCEPHALUS 31
680 HYPERCAPNIA 31
681 HYPOTONIA NEONATAL 31
682 INJECTION SITE PAIN 31
683 LEFT VENTRICULAR HYPERTROPHY 31
684 NEUTROPHILIA 31
685 NEW ONSET REFRACTORY STATUS EPILEPTICUS 31
686 PARALYSIS 31
687 SUBSTANCE ABUSE 31
688 ACTIVITIES OF DAILY LIVING IMPAIRED 30
689 BLOOD POTASSIUM DECREASED 30
690 BONE PAIN 30
691 CANDIDA INFECTION 30
692 CARDIOMYOPATHY 30
693 FRACTURE 30
694 GYNAECOMASTIA 30
695 HYDRONEPHROSIS 30
696 MITRAL VALVE INCOMPETENCE 30
697 MONOCYTE COUNT INCREASED 30
698 NEONATAL RESPIRATORY DISTRESS SYNDROME 30
699 NIGHTMARE 30
700 PLAGIOCEPHALY 30
701 PLATELET COUNT INCREASED 30
702 PNEUMATOSIS 30
703 SINUSITIS 30
704 SKIN DISORDER 30
705 SKIN ULCER 30
706 SPLENOMEGALY 30
707 STARING 30
708 STRABISMUS 30
709 TENSION 30
710 BLOOD GASES ABNORMAL 29
711 CEREBELLAR SYNDROME 29
712 DIABETES MELLITUS INADEQUATE CONTROL 29
713 DISABILITY 29
714 DROP ATTACKS 29
715 GASTRITIS 29
716 GASTROINTESTINAL NECROSIS 29
717 LARGE INTESTINE PERFORATION 29
718 LUNG INFILTRATION 29
719 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 29
720 MOTOR DEVELOPMENTAL DELAY 29
721 MULTIPLE CONGENITAL ABNORMALITIES 29
722 NEURODEVELOPMENTAL DISORDER 29
723 NEUROLOGICAL DECOMPENSATION 29
724 POLYURIA 29
725 PRODUCT DOSE OMISSION 29
726 PUPILLARY REFLEX IMPAIRED 29
727 SUBDURAL HAEMATOMA 29
728 TONIC CLONIC MOVEMENTS 29
729 VENTRICULAR ARRHYTHMIA 29
730 ACUTE MYOCARDIAL INFARCTION 28
731 BEDRIDDEN 28
732 BLADDER DISORDER 28
733 BLINDNESS 28
734 BUNDLE BRANCH BLOCK RIGHT 28
735 CLOSTRIDIUM DIFFICILE COLITIS 28
736 CONGENITAL FOOT MALFORMATION 28
737 CONJUNCTIVAL HYPERAEMIA 28
738 DERMATITIS BULLOUS 28
739 DRUG LEVEL CHANGED 28
740 EPSTEIN-BARR VIRUS INFECTION 28
741 FLATULENCE 28
742 GLYCOSURIA 28
743 LOW SET EARS 28
744 MUCOSAL INFLAMMATION 28
745 PROTHROMBIN TIME PROLONGED 28
746 SUBARACHNOID HAEMORRHAGE 28
747 SUBSTANCE USE 28
748 ABDOMINAL PAIN LOWER 27
749 ASPHYXIA 27
750 BACTERIAL INFECTION 27
751 BRAIN HERNIATION 27
752 CHOREA 27
753 CLONIC CONVULSION 27
754 COGWHEEL RIGIDITY 27
755 CONGENITAL HAND MALFORMATION 27
756 DRUG-DISEASE INTERACTION 27
757 DYSLIPIDAEMIA 27
758 ECCHYMOSIS 27
759 FEBRILE CONVULSION 27
760 HALLUCINATIONS, MIXED 27
761 HYPERTROPHIC CARDIOMYOPATHY 27
762 ISCHAEMIC STROKE 27
763 MALNUTRITION 27
764 MUTISM 27
765 PANCREATITIS NECROTISING 27
766 PARKINSON^S DISEASE 27
767 PERIORBITAL OEDEMA 27
768 POLLAKIURIA 27
769 PULMONARY CONGESTION 27
770 THERAPY CESSATION 27
771 TINNITUS 27
772 VASCULAR ENCEPHALOPATHY 27
773 VENTRICULAR EXTRASYSTOLES 27
774 WHEEZING 27
775 BLOOD SODIUM INCREASED 26
776 COELIAC DISEASE 26
777 CYTOPENIA 26
778 DRUG ADMINISTRATION ERROR 26
779 EDUCATIONAL PROBLEM 26
780 FREQUENT BOWEL MOVEMENTS 26
781 GALACTORRHOEA 26
782 INFUSION RELATED REACTION 26
783 INTRACRANIAL PRESSURE INCREASED 26
784 LIPASE INCREASED 26
785 LIVE BIRTH 26
786 TORTICOLLIS 26
787 ABASIA 25
788 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 25
789 ANTICHOLINERGIC SYNDROME 25
790 ANTINUCLEAR ANTIBODY POSITIVE 25
791 ASCITES 25
792 CENTRAL SLEEP APNOEA SYNDROME 25
793 CLEFT LIP AND PALATE 25
794 DELUSION OF GRANDEUR 25
795 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25
796 DYSMETRIA 25
797 DYSPRAXIA 25
798 EYE PAIN 25
799 HYPERCHOLESTEROLAEMIA 25
800 HYPERTELORISM OF ORBIT 25
801 HYPOREFLEXIA 25
802 INGUINAL HERNIA 25
803 LYMPHOPENIA 25
804 MYELODYSPLASTIC SYNDROME 25
805 OLIGURIA 25
806 PRODUCT ADMINISTRATION INTERRUPTED 25
807 RED BLOOD CELL SEDIMENTATION RATE INCREASED 25
808 STEREOTYPY 25
809 AUTISM 24
810 BLOOD PH DECREASED 24
811 BLOOD THYROID STIMULATING HORMONE DECREASED 24
812 DECUBITUS ULCER 24
813 DISTURBANCE IN SOCIAL BEHAVIOUR 24
814 DYSPNOEA EXERTIONAL 24
815 GASTROENTERITIS VIRAL 24
816 HAEMORRHAGE INTRACRANIAL 24
817 HEMIPLEGIA 24
818 HYPOVOLAEMIC SHOCK 24
819 LIP SWELLING 24
820 MITOCHONDRIAL TOXICITY 24
821 NEOVASCULARISATION 24
822 OBSESSIVE-COMPULSIVE DISORDER 24
823 OTITIS MEDIA 24
824 RASH MORBILLIFORM 24
825 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 24
826 ACNE 23
827 ACUTE PSYCHOSIS 23
828 CENTRAL NERVOUS SYSTEM LESION 23
829 COLITIS ISCHAEMIC 23
830 CYSTITIS 23
831 DYSSTASIA 23
832 EAR MALFORMATION 23
833 ECZEMA 23
834 EYE SWELLING 23
835 FEELING HOT 23
836 JOINT DISLOCATION 23
837 MYOCARDIAL ISCHAEMIA 23
838 NASAL CONGESTION 23
839 PLEOCYTOSIS 23
840 POTENTIATING DRUG INTERACTION 23
841 RENAL DISORDER 23
842 RENAL TUBULAR DISORDER 23
843 RHINORRHOEA 23
844 WRONG TECHNIQUE IN DRUG USAGE PROCESS 23
845 ANAEMIA MACROCYTIC 22
846 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 22
847 AREFLEXIA 22
848 CATARACT 22
849 CEREBRAL VENTRICLE DILATATION 22
850 DISSOCIATION 22
851 ENCEPHALITIS AUTOIMMUNE 22
852 HERNIA 22
853 HYPERCHLORAEMIA 22
854 HYPOPNOEA 22
855 ILLUSION 22
856 LEFT VENTRICULAR DYSFUNCTION 22
857 LENNOX-GASTAUT SYNDROME 22
858 NEPHROCALCINOSIS 22
859 POSTICTAL PARALYSIS 22
860 POSTICTAL PSYCHOSIS 22
861 PRESYNCOPE 22
862 PRODUCT AVAILABILITY ISSUE 22
863 PUPIL FIXED 22
864 QUALITY OF LIFE DECREASED 22
865 SKIN INFECTION 22
866 SUPERINFECTION 22
867 SYDENHAM^S CHOREA 22
868 SYSTEMIC LUPUS ERYTHEMATOSUS 22
869 ACCIDENTAL EXPOSURE TO PRODUCT 21
870 ADVERSE REACTION 21
871 ANAPHYLACTIC REACTION 21
872 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21
873 BLEPHAROSPASM 21
874 BRUGADA SYNDROME 21
875 CARDIAC FAILURE CONGESTIVE 21
876 CSF OLIGOCLONAL BAND PRESENT 21
877 DRY SKIN 21
878 EPILEPTIC ENCEPHALOPATHY 21
879 FANCONI SYNDROME ACQUIRED 21
880 FEEDING DISORDER NEONATAL 21
881 FIBRIN D DIMER INCREASED 21
882 FIBROMYALGIA 21
883 HICCUPS 21
884 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 21
885 IDIOSYNCRATIC DRUG REACTION 21
886 INTENTIONAL DOSE OMISSION 21
887 INTERSTITIAL LUNG DISEASE 21
888 LYMPHOCYTE COUNT INCREASED 21
889 MEDICATION RESIDUE 21
890 MUCOSAL ULCERATION 21
891 NEPHROGENIC DIABETES INSIPIDUS 21
892 OCULAR HYPERAEMIA 21
893 OSCILLOPSIA 21
894 PAROXYSMAL PERCEPTUAL ALTERATION 21
895 POST PROCEDURAL COMPLICATION 21
896 PRODUCT PRESCRIBING ISSUE 21
897 PSEUDOMONAS INFECTION 21
898 RESPIRATION ABNORMAL 21
899 RESPIRATORY RATE DECREASED 21
900 THERAPEUTIC AGENT TOXICITY 21
901 THERAPEUTIC PRODUCT CROSS-REACTIVITY 21
902 VAGAL NERVE STIMULATOR IMPLANTATION 21
903 VITAMIN D DEFICIENCY 21
904 ABNORMAL WEIGHT GAIN 20
905 AKINESIA 20
906 ASOCIAL BEHAVIOUR 20
907 BLOOD BICARBONATE DECREASED 20
908 BODY TEMPERATURE DECREASED 20
909 BONE DENSITY DECREASED 20
910 CLOSTRIDIUM DIFFICILE INFECTION 20
911 CONGENITAL ORAL MALFORMATION 20
912 DELUSIONAL DISORDER, UNSPECIFIED TYPE 20
913 DISORGANISED SPEECH 20
914 DISTRACTIBILITY 20
915 FEELING JITTERY 20
916 FOETAL GROWTH RESTRICTION 20
917 GESTATIONAL DIABETES 20
918 HAEMOPTYSIS 20
919 IMPAIRED HEALING 20
920 INHIBITORY DRUG INTERACTION 20
921 LEUKAEMIA 20
922 LIP HAEMORRHAGE 20
923 MONOCYTE COUNT DECREASED 20
924 MYOPATHY 20
925 PHOTOPHOBIA 20
926 PHOTOPSIA 20
927 POSTURAL TREMOR 20
928 PULMONARY ALVEOLAR HAEMORRHAGE 20
929 PULSELESS ELECTRICAL ACTIVITY 20
930 RHINOVIRUS INFECTION 20
931 SMALL FOR DATES BABY 20
932 THIRST 20
933 TRANSIENT ISCHAEMIC ATTACK 20
934 UROSEPSIS 20
935 APRAXIA 19
936 ARTERIOSCLEROSIS 19
937 BLOOD DISORDER 19
938 DERMATITIS EXFOLIATIVE 19
939 EXTRA DOSE ADMINISTERED 19
940 FAECAL INCONTINENCE 19
941 FAILURE TO SUSPEND MEDICATION 19
942 FAILURE TO THRIVE 19
943 GASTRIC DISORDER 19
944 GASTROENTERITIS 19
945 HEART RATE IRREGULAR 19
946 KLEBSIELLA INFECTION 19
947 LOSS OF LIBIDO 19
948 MEDICATION OVERUSE HEADACHE 19
949 MULTIPLE DRUG THERAPY 19
950 NECROTISING COLITIS 19
951 NEURALGIA 19
952 PLEURISY 19
953 POSTICTAL STATE 19
954 PROCALCITONIN INCREASED 19
955 PULMONARY HYPERTENSION 19
956 RASH PAPULAR 19
957 RENAL FUSION ANOMALY 19
958 SECRETION DISCHARGE 19
959 SENSORY DISTURBANCE 19
960 SIMPLE PARTIAL SEIZURES 19
961 SLUGGISHNESS 19
962 STAPHYLOCOCCAL BACTERAEMIA 19
963 WITHDRAWAL CATATONIA 19
964 ANOREXIA 18
965 APLASIA PURE RED CELL 18
966 APLASTIC ANAEMIA 18
967 ATRIOVENTRICULAR BLOCK 18
968 BLOOD CALCIUM DECREASED 18
969 BLOOD PHOSPHORUS INCREASED 18
970 BONE DISORDER 18
971 BRAIN NEOPLASM 18
972 CARDIOTOXICITY 18
973 CELL DEATH 18
974 CEREBRAL ISCHAEMIA 18
975 DEVICE RELATED INFECTION 18
976 EJECTION FRACTION DECREASED 18
977 ENERGY INCREASED 18
978 EXPRESSIVE LANGUAGE DISORDER 18
979 FOOT FRACTURE 18
980 GINGIVAL BLEEDING 18
981 HEPATIC ENZYME ABNORMAL 18
982 HEPATIC NECROSIS 18
983 HYPERCALCAEMIA 18
984 HYPERPHAGIA 18
985 HYPERPYREXIA 18
986 INTERVERTEBRAL DISC PROTRUSION 18
987 METABOLIC SYNDROME 18
988 MICTURITION URGENCY 18
989 MOUTH HAEMORRHAGE 18
990 MYOPIA 18
991 NIKOLSKY^S SIGN 18
992 OBSTRUCTIVE AIRWAYS DISORDER 18
993 OSTEOARTHRITIS 18
994 PERSONALITY CHANGE 18
995 PHOTOSENSITIVITY REACTION 18
996 PNEUMONIA PSEUDOMONAL 18
997 PNEUMONITIS 18
998 POOR VENOUS ACCESS 18
999 PYLORIC STENOSIS 18